ARCHIVES

Beth Israel Suspends Enrollment In Trials Following An Audit

This article is from The Cancer Letter archive.

Vol. 36 No. 38 | October 22, 2010

Download PDF Visit The Full Archive

Related Articles

Investigational Drug Radium-223 Chloride Improved Overall Survival By 44 Percent

September 30, 2011

$3.3 Million For Retinoid Contract Awarded

October 14, 1977

DCT Board Okays Six Contract Recompetitions

October 23, 1987

Fox Chase Cancer Center plans $1 billion expansion that would double its size.

October 22, 2004

FDA Approves Arranon For Leukemia And Lymphoma

December 30, 2005

ASH Highlights: Improved Treatments For NHL, Poor Prognostic Factors For B-Cell In Children

January 30, 2004